Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruffo

Showing results (701-710 of 705) with videos related to

Pageof 71
Sort By:
You have reached the last page of results.This site can display upto 705 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
Neuron|May 3, 2024
Genome sequence analyses identify novel risk loci for multiple system atrophyRuth Chia, Anindita Ray, Zalak Shah, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Biological Conservation|May 26, 2021
Global COVID-19 lockdown highlights humans as both threats and custodians of the environmentAmanda E Bates, Richard B Primack, Brandy S Biggar, et al.
Pageof 71

Showing results (701-710 of 705) with videos related to

Sort By:
Pageof 71
You have reached the last page of results.This site can display upto 705 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
Neuron|May 3, 2024
Genome sequence analyses identify novel risk loci for multiple system atrophyRuth Chia, Anindita Ray, Zalak Shah, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Biological Conservation|May 26, 2021
Global COVID-19 lockdown highlights humans as both threats and custodians of the environmentAmanda E Bates, Richard B Primack, Brandy S Biggar, et al.
Pageof 71